Cargando…
Reducing VEGFB accelerates NAFLD and insulin resistance in mice via inhibiting AMPK signaling pathway
OBJECTIVE: Vascular endothelial growth factor B (VEGFB) was regarded to improve lipid metabolism and reduce obesity-related hyperlipidemia. Whether VEGFB participates in lipid metabolism in nonalcoholic fatty liver disease (NAFLD) has not been clear yet. This study investigated the involvement of VE...
Autores principales: | Li, Rongrong, Li, Yuqi, Yang, Xueling, Hu, Yaorui, Yu, Haining, Li, Yana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338666/ https://www.ncbi.nlm.nih.gov/pubmed/35907871 http://dx.doi.org/10.1186/s12967-022-03540-2 |
Ejemplares similares
-
Reducing VEGFB expression regulates the balance of glucose and lipid metabolism in mice via VEGFR1
por: Luo, Xu, et al.
Publicado: (2022) -
VEGFB Promotes Myoblasts Proliferation and Differentiation through VEGFR1-PI3K/Akt Signaling Pathway
por: Ling, Mingfa, et al.
Publicado: (2021) -
Knockdown of VEGFB/VEGFR1 Signaling Promotes White Adipose Tissue Browning and Skeletal Muscle Development
por: Ling, Mingfa, et al.
Publicado: (2022) -
Rhinacanthin C Ameliorates Insulin Resistance and Lipid Accumulation in NAFLD Mice via the AMPK/SIRT1 and SREBP-1c/FAS/ACC Signaling Pathways
por: Gong, Zhiqiang, et al.
Publicado: (2023) -
Oleuropein Induces AMPK-Dependent Autophagy in NAFLD Mice, Regardless of the Gender
por: Porcu, Cristiana, et al.
Publicado: (2018)